Developer of an imaging system designed to improve patient outcomes at a reduced cost by applying artificial intelligence to vascular diagnostic imaging. Elucid Bioimaging is based in Boston, MA. It was valued at $288 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $163 million across 3 recorded rounds; the latest was a $36.5 million early-stage round in Oct 2025.
PMV mark · valuation
$288.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$163.2M
Last round
Early Stage VC
Oct 2025
Team — not yet on record
No current team members for Elucid Bioimaging are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Elucid Bioimaging with a free account
·The complete investor list: 24 names
·Watch Elucid Bioimaging: the Monday email on marks, rounds and moves
